Christopher N. Kaufmann

Christopher N. Kaufmann

Auto-generated profile, based on publicly available information

Christopher N. Kaufmann

Department of Health Outcomes and Biomedical Informatics, University of Florida College of Medicine, Gainesville, FL, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2020 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
PDF file
KYKevin H. Yang
Kevin H. Yang
CKChristopher N. Kaufmann
Christopher N. Kaufmann
RNReva Nafsu
Reva Nafsu
ELElla T. Lifset
Ella T. Lifset
KNKhai Nguyen
Khai Nguyen
AMAlison A. Moore
Alison A. Moore

29 December 2015 in Pharmacoepidemiology and Drug Safety
Verified
Journal Article
Closed access
PDF file
CKChristopher N. Kaufmann
Christopher N. Kaufmann
ASAdam P. Spira
Adam P. Spira
GAG. Caleb Alexander
G. Caleb Alexander
LRLainie Rutkow
Lainie Rutkow
RMRamin Mojtabai
Ramin Mojtabai

1 July 2016 in The American Journal of Geriatric Psychiatry
Verified
Journal Article
Closed access
CKChristopher N. Kaufmann
Christopher N. Kaufmann
RMRamin Mojtabai
Ramin Mojtabai
RHRebecca S. Hock
Rebecca S. Hock
RTRoland J. Thorpe
Roland J. Thorpe
SCSarah L. Canham
Sarah L. Canham
ASAdam P. Spira
Adam P. Spira

1 February 2018 in Psychiatric Services
Verified
Journal Article
Closed access
CKChristopher N. Kaufmann
Christopher N. Kaufmann
ASAdam P. Spira
Adam P. Spira
CDColin A. Depp
Colin A. Depp
RMRamin Mojtabai
Ramin Mojtabai

1 April 2022 in Cannabis & Cannabinoid Research
Verified
Journal Article
Closed access
CKChristopher N. Kaufmann
Christopher N. Kaufmann
AKArum Kim
Arum Kim
MMMari Miyoshi
Mari Miyoshi
BHBenjamin H. Han
Benjamin H. Han
Background: Cannabis use has increased among older adults. Few epidemiological studies have examined the medical diseases reported for cannabis use, routes of cannabis administration, and methods of consumption among older adults, and how they differ from younger adults. Methods: We analyzed invoice data on purchases of cannabis products from a large medical cannabis dispensary in New York State between January 1, 2016 and December 31, 2017. Data came from n =11,590 patients stratified by ages 18–49 ( n =4,606), 50–64 ( n =3,993), and ≥65 years ( n =2,991). We assessed differences in groups by demographic characteristics of patients, qualifying conditions and symptoms for cannabis use, cannabis product dosing of THC and CBD, THC:CBD ratios, and cannabis delivery methods. Results: Among cannabis patients, 25.8% were aged ≥65 years, and 34.5% were ages 50–64. Across all age groups, severe or chronic pain was the predominant symptom for cannabis use, although older patients were more likely to use cannabis for cancer and Parkinson's disease among other conditions. Older adults were more likely to use sublingual tincture versus other consumption methods, to use products with a lower THC:CBD ratio, and to begin cannabis treatment with a lower THC and higher CBD dose compared with younger age groups. However, all age groups demonstrated a similar increase in THC dosing over time. Conclusion: Analysis of medical cannabis invoices from a dispensary in New York State showed that although there are similarities in patterns of cannabis use across all groups, there are key characteristics unique to the older adult medical cannabis user.

1 August 2017 in Sleep Health
Verified
Journal Article
Closed access
CKChristopher N. Kaufmann
Christopher N. Kaufmann
RSRyoko Susukida
Ryoko Susukida
CDColin A. Depp
Colin A. Depp